Main adverse reactions motivating the substitution of Dolutegravir in Antiretroviral Therapy regimens in Brazil

Main adverse reactions motivating the substitution of Dolutegravir in Antiretroviral Therapy regimens in Brazil
Publicações: 
*Poster Aids 2018
HIV/Aids
Last modified: 
31.07.2018 - 10:39
Data da publicação: 
18.07.2018

Author: Cynthia Batista
Phone: +55 61 3315-7635
email: cynthia.batista@aids.gov.br

AttachmentSize
Main adverse reactions motivating the substitution of Dolutegravir in Antiretroviral Therapy regimens in Brazil1.67 MB
Tratamento